Aprogen pharmaceuticals Inc (003060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Aprogen pharmaceuticals Inc (Aprogen), formerly Schnell Biopharmaceuticals Inc is a healthcare company that provides agents and antibiotics. The company offers pharmaceutical products such as amino acid infusion agents and antibiotics. It provides products portfolio such as antibiotics, infusions, containing amino acid, vitamin and hepatic protect infusions; gastrointestinal agents, comprising of digestives, antiulcerants, and others. Aprogen provides musculoskeletal system agents, consisting of anti-inflammatory drugs, muscle relaxants, respiratory system agents, including expectorants, antitussives and antihistamines, among others. The company produces vitamins and nutrition agents. It offers the other drugs such as antiemetics and antineoplastic agents. The company operates through its factory located in Hwaseong-si, Korea. Aprogen is headquartered in Seongnam, South Korea.

Aprogen pharmaceuticals Inc (003060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Binex Forms Joint Venture with Aprogen 11
Debt Offering 12
Aprogen Pharma Raises USD20.6 Million in Public Offering of 2% Bonds Due 2022 12
Schnell Biopharma to Raise USD10 Million in Public Offering of 2% Bonds Due 2019 13
Schnell Biopharma to Raise USD9.2 Million in Public Offering of 2% Bonds Due 2019 14
Acquisition 15
Huacheng Travel Agency Plans to Acquire Schnell Biopharma 15
Gbase to Acquire 22% Stake in Aprogen for USD16 Million 16
Binex Completes Acquisition of 22% Stake in Aprogen for USD14 million 17
Schnell Biopharma Sells 50% Stake In CHUNG GEI Pharma For US$6.5 Million 18
Aprogen pharmaceuticals Inc - Key Competitors 19
Aprogen pharmaceuticals Inc - Key Employees 20
Aprogen pharmaceuticals Inc - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List Of Tables


Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aprogen pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Binex Forms Joint Venture with Aprogen 11
Aprogen Pharma Raises USD20.6 Million in Public Offering of 2% Bonds Due 2022 12
Schnell Biopharma to Raise USD10 Million in Public Offering of 2% Bonds Due 2019 13
Schnell Biopharma to Raise USD9.2 Million in Public Offering of 2% Bonds Due 2019 14
Huacheng Travel Agency Plans to Acquire Schnell Biopharma 15
Gbase to Acquire 22% Stake in Aprogen for USD16 Million 16
Binex Completes Acquisition of 22% Stake in Aprogen for USD14 million 17
Schnell Biopharma Sells 50% Stake In CHUNG GEI Pharma For US$6.5 Million 18
Aprogen pharmaceuticals Inc, Key Competitors 19
Aprogen pharmaceuticals Inc, Key Employees 20
Aprogen pharmaceuticals Inc, Other Locations 21
Aprogen pharmaceuticals Inc, Subsidiaries 21

List Of Figures


Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aprogen pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Aprogen pharmaceuticals Inc (003060) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Aprogen pharmaceuticals Inc (Aprogen), formerly Schnell Biopharmaceuticals Inc is a healthcare company that provides agents and antibiotics. The company offers pharmaceutical products such as amino acid infusion agents and antibiotics.

USD 250 View Report

Aprogen pharmaceuticals Inc (003060) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Aprogen pharmaceuticals Inc (Aprogen), formerly Schnell Biopharmaceuticals Inc is a healthcare company that provides agents and antibiotics. The company offers pharmaceutical products such as amino acid infusion agents and antibiotics.

USD 250 View Report

Cannabics Pharmaceuticals Inc (CNBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cannabics Pharmaceuticals Inc (Cannabics Pharmaceuticals), formerly Thrust Energy Corp, is a drug development company that develops cannabinoid-based therapies for cancer. The company develops High Content Screening (HCS) Platform, an automated

USD 250 View Report

Amneal Pharmaceuticals Inc (AMRX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Amneal Pharmaceuticals Inc (Amneal) formerly Amneal Pharmaceuticals LLC, is an integrated specialty pharmaceutical company that produces generic, specialty and biosimilar medicines. Its product portfolio includes generic and specialty drugs in

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available